DE602004020632D1 - Verfahren zur herstellung einer alpha-1-antitrypsinlösung - Google Patents

Verfahren zur herstellung einer alpha-1-antitrypsinlösung

Info

Publication number
DE602004020632D1
DE602004020632D1 DE602004020632T DE602004020632T DE602004020632D1 DE 602004020632 D1 DE602004020632 D1 DE 602004020632D1 DE 602004020632 T DE602004020632 T DE 602004020632T DE 602004020632 T DE602004020632 T DE 602004020632T DE 602004020632 D1 DE602004020632 D1 DE 602004020632D1
Authority
DE
Germany
Prior art keywords
a1at
preparing
solution
antitrypsine
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004020632T
Other languages
German (de)
English (en)
Inventor
Petra Schulz
Juergen Roemisch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Octapharma AG
Original Assignee
Octapharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma AG filed Critical Octapharma AG
Publication of DE602004020632D1 publication Critical patent/DE602004020632D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE602004020632T 2003-08-12 2004-08-12 Verfahren zur herstellung einer alpha-1-antitrypsinlösung Expired - Lifetime DE602004020632D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49409703P 2003-08-12 2003-08-12
PCT/EP2004/009043 WO2005014648A1 (en) 2003-08-12 2004-08-12 Process for preparing an alpha-1-antitrypsin solution

Publications (1)

Publication Number Publication Date
DE602004020632D1 true DE602004020632D1 (de) 2009-05-28

Family

ID=34135316

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004020632T Expired - Lifetime DE602004020632D1 (de) 2003-08-12 2004-08-12 Verfahren zur herstellung einer alpha-1-antitrypsinlösung

Country Status (22)

Country Link
US (1) US20060194300A1 (enExample)
EP (1) EP1654284B1 (enExample)
JP (1) JP4668904B2 (enExample)
KR (1) KR20060070543A (enExample)
CN (1) CN1867582B (enExample)
AT (1) ATE428730T1 (enExample)
AU (1) AU2004262578B2 (enExample)
BR (1) BRPI0412835A (enExample)
CA (1) CA2534900A1 (enExample)
DE (1) DE602004020632D1 (enExample)
DK (1) DK1654284T3 (enExample)
ES (1) ES2324168T3 (enExample)
IL (1) IL172868A0 (enExample)
NO (1) NO20060109L (enExample)
PL (1) PL1654284T3 (enExample)
PT (1) PT1654284E (enExample)
RS (1) RS20060077A (enExample)
RU (1) RU2370500C2 (enExample)
SI (1) SI1654284T1 (enExample)
UA (1) UA86775C2 (enExample)
WO (1) WO2005014648A1 (enExample)
ZA (1) ZA200601206B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1664123T2 (sl) * 2003-09-22 2012-03-30 Kamada Ltd Priprava inhibitorja alfa proteinaze v velikem merilu in njegova uporaba
ES2246694B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Nanoparticulas pegiladas.
ES2246695B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
CN100354301C (zh) * 2005-10-13 2007-12-12 南京工业大学 化学合成多肽的新型大规模分离制备技术
US20110002909A1 (en) * 2007-11-02 2011-01-06 Vikram Arora Method, composition, and article of manufacture for providing alpha-1 antitrypsin
CN102127165B (zh) * 2010-01-15 2013-09-04 上海莱士血液制品股份有限公司 一种从血浆组分四沉淀中制备高纯ApoA-I的生产工艺
CN102731642B (zh) * 2011-04-14 2014-01-29 上海莱士血液制品股份有限公司 从人血浆组分四沉淀制备高纯Apoa-I的生产工艺
US9353165B2 (en) * 2012-07-25 2016-05-31 Grifols, S.A. Purification of cell culture derived alpha1 protease inhibitor
AU2013205138B2 (en) * 2012-08-09 2015-06-25 Grifols, S.A. Caprylate Viral Deactivation
JP6845813B2 (ja) * 2015-06-26 2021-03-24 フェリング ベスローテン フェンノートシャップ 精製および／またはウイルス不活性化の方法
MX2018009331A (es) * 2016-02-03 2018-11-09 Plasma Tech Llc Metodos para extraer proteinas a partir de un material a base de sangre.
SG11202003793WA (en) 2017-10-30 2020-05-28 Baxalta GmbH Environmentally compatible detergents for inactivation of lipid-enveloped viruses
CN111991571B (zh) * 2020-08-12 2022-04-05 湖州师范学院 一种柱上低pH病毒灭活的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS584728A (ja) * 1981-05-01 1983-01-11 メデイカル・リサ−チ・インステイチユ−ト・オブ・サンフランシスコ・コ−ポレ−シヨン α−１−抗トリプシンの精製
US4379087A (en) * 1982-06-17 1983-04-05 Cutter Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
US4629567A (en) * 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification
ES2053606T3 (es) * 1987-04-27 1994-08-01 Miles Inc Metodo de preparacion de un inhibidor de alfa-1-proteinasa de alta pureza.
KR920005689B1 (ko) * 1989-12-21 1992-07-13 국제약품공업주식회사 혈청으로부터 알파-1-안티트립신의 분리 정제 및 혈중 알파-1-안티트립신 양의 검정키트
DE4125625C2 (de) * 1991-08-02 1999-12-02 Octapharma Ag Glarus Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen
SE9301582D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Purification of plasma proteins
DE4407837C1 (de) * 1994-03-09 1995-08-17 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem alpha¶1¶-Antitrypsin mittels Anionenaustauscher-Chromatographie
US6284874B1 (en) * 1994-06-17 2001-09-04 Alpha Therapeutic Corporation Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste
AU6884396A (en) * 1995-09-07 1997-03-27 Ppl Therapeutics (Scotland) Ltd Purification of alpha-1 proteinase inhibitor
JP4105249B2 (ja) * 1996-08-09 2008-06-25 財団法人化学及血清療法研究所 α２プラスミンインヒビターの製造方法
AT407114B (de) * 1997-06-10 2000-12-27 Immuno Ag Alpha 1-antitrypsin-präparation sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
ATE428730T1 (de) 2009-05-15
PT1654284E (pt) 2009-07-06
RS20060077A (sr) 2008-08-07
UA86775C2 (ru) 2009-05-25
WO2005014648A1 (en) 2005-02-17
KR20060070543A (ko) 2006-06-23
CN1867582A (zh) 2006-11-22
EP1654284B1 (en) 2009-04-15
RU2006107533A (ru) 2006-07-27
CN1867582B (zh) 2010-06-16
JP2007523883A (ja) 2007-08-23
AU2004262578A1 (en) 2005-02-17
ES2324168T3 (es) 2009-07-31
US20060194300A1 (en) 2006-08-31
IL172868A0 (en) 2006-06-11
DK1654284T3 (da) 2009-07-20
EP1654284A1 (en) 2006-05-10
RU2370500C2 (ru) 2009-10-20
PL1654284T3 (pl) 2009-09-30
SI1654284T1 (sl) 2009-10-31
NO20060109L (no) 2006-02-15
CA2534900A1 (en) 2005-02-17
BRPI0412835A (pt) 2006-09-26
ZA200601206B (en) 2007-05-30
AU2004262578B2 (en) 2010-05-06
JP4668904B2 (ja) 2011-04-13

Similar Documents

Publication Publication Date Title
DE602004020632D1 (de) Verfahren zur herstellung einer alpha-1-antitrypsinlösung
ES8702793A1 (es) Un procedimiento para desinfectar un substrato
BR0115730A (pt) materiais antimicrobianos foto-estabilizados
RU95108231A (ru) Glp-1-молекулярный комплекс, фармацевтическая композиция и способ получения комплекса
BRPI0412321A (pt) limpeza de membranas de filtração com peróxidos
DK1301201T3 (da) Behandling af glycogenosis type II
NO20006606L (no) Fremgangsmåte for fremstilling av en vandig monoester peroksykarboksylsyreopplösning, opplösningen som kan oppnås ved denne fremgangsmåten og dens anvendelse som desinfeksjonsmiddel
WO2004037784A3 (en) Pyrrolidones with anti-hiv activity
PE103799A1 (es) Procedimiento de purificacion de mesilato de alatrofloxacino
ATE494894T1 (de) Viruzide wirkungen von einer zubereitung enthaltend cetylpyridiniumchlorid und zitronensäure
BR0107967A (pt) Solução de composto de amÈnio quaternário concentrada e processo para evitar a proliferação de microorganismo em um produto alimentìcio
PL1718673T3 (pl) Sposób oczyszczania albuminy obejmujący etap nanofiltracji, roztwór, i zawierająca go kompozycja do terapeutycznego zastosowania
ATE374022T1 (de) Oxaliplatinlösungskonzentrate
BRPI0407448A (pt) Processo quìmico
WO2004037853A3 (en) Quinolones with anti-hiv activity
BR9807154A (pt) Processo para a produção de um composto de 2,3-di-hidroxipropilaamino, e , composto.
BRPI0416274A (pt) método para produzir solução de amÈnio de ácido orgánico
EA200800785A1 (ru) 4-арил-1,4-дигидро-3(2н)-изохинолиноны и 4-арил-1,2,3,4-тетрагидроизохинолины в качестве ингибиторов igf-1r и в качестве фармакологического средства в тест-системах, фармацевтическая композиция и изделие на их основе и способ лечения заболеваний, опосредованных igf-1 рецептором
RU99127483A (ru) Способ бальзамирования анатомических препаратов силоксановыми композициями
EP1634589A4 (en) AQUEOUS OLANEXIDINE SOLUTION, MANUFACTURING METHOD AND DISINFECTANT
IT1265964B1 (it) Micro-granuli ottenuti tramite estrusione-sferonizzazione contenenti una ciclodestrina.
EP0675905A1 (en) OLIGOSACCHARIDES HAVING BIOLOGICAL ACTIVITY AND THEIR PREPARATION FROM GLYCOSAMINOGLYCANS.
BRPI0012150B8 (pt) processo para estabilizar proteínas em misturas complexas na armazenagem em solventes aquosos, bem como de preparação de uma proteína heteróloga
DE602004032024D1 (de) Behandlung hochleistungsfähiger pigmentfarbstoffe mit dispergierenden etheramin-salzen
AR002510A1 (es) Un procedimiento para la preparacion de derivados de 1-(3-trialquilsilil- fenil)-2,2,2-trifluorometiletanona que son utiles en el tratamiento de laenfermedad de alzheimer y demencia senil y procedimiento para la purificacion de dicho derivado con dicho procedimiento de preparacion.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition